These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32721391)
21. PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1. Huo FC; Pan YJ; Li TT; Mou J; Pei DS Cell Death Differ; 2019 Jun; 26(6):994-1006. PubMed ID: 30082769 [TBL] [Abstract][Full Text] [Related]
22. FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1. Yu J; Peng W; Xue Y; Li Y; Yang L; Geng Y Allergol Immunopathol (Madr); 2022; 50(5):68-74. PubMed ID: 36086966 [TBL] [Abstract][Full Text] [Related]
23. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871 [TBL] [Abstract][Full Text] [Related]
24. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification. Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525 [TBL] [Abstract][Full Text] [Related]
25. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2. Huang Z; Shen G; Gao J Clin Transl Oncol; 2021 Sep; 23(9):1743-1751. PubMed ID: 33721187 [TBL] [Abstract][Full Text] [Related]
26. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Xiang R; Liao D; Cheng T; Zhou H; Shi Q; Chuang TS; Markowitz D; Reisfeld RA; Luo Y Br J Cancer; 2011 Apr; 104(9):1410-7. PubMed ID: 21468047 [TBL] [Abstract][Full Text] [Related]
27. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis. Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697 [TBL] [Abstract][Full Text] [Related]
28. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling. Gao H; Teng C; Huang W; Peng J; Wang C Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway. Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079 [TBL] [Abstract][Full Text] [Related]
30. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934 [TBL] [Abstract][Full Text] [Related]
31. NF-YA Overexpression in Lung Cancer: LUSC. Bezzecchi E; Ronzio M; Dolfini D; Mantovani R Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31744190 [TBL] [Abstract][Full Text] [Related]
32. Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition. Tao Y; Fei L; Chang L; Yongyu L; Jianhui J; Yanan L; Yi R Genes Genomics; 2022 Feb; 44(2):211-218. PubMed ID: 34086268 [TBL] [Abstract][Full Text] [Related]
33. Fibroblast‑derived exosomal microRNA‑369 potentiates migration and invasion of lung squamous cell carcinoma cells via NF1‑mediated MAPK signaling pathway. Guo L; Li B; Yang J; Shen J; Ji J; Miao M Int J Mol Med; 2020 Aug; 46(2):595-608. PubMed ID: 32467987 [TBL] [Abstract][Full Text] [Related]
34. Multiple mutations of lung squamous cell carcinoma shared common mechanisms. Li Q; Hou J; Hu Z; Gu B; Shi Y Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590 [TBL] [Abstract][Full Text] [Related]
35. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
36. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma. Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162 [TBL] [Abstract][Full Text] [Related]
37. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Wilbertz T; Wagner P; Petersen K; Stiedl AC; Scheble VJ; Maier S; Reischl M; Mikut R; Altorki NK; Moch H; Fend F; Staebler A; Bass AJ; Meyerson M; Rubin MA; Soltermann A; Lengerke C; Perner S Mod Pathol; 2011 Jul; 24(7):944-53. PubMed ID: 21460799 [TBL] [Abstract][Full Text] [Related]
38. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells. Yang N; Wang Y; Hui L; Li X; Jiang X J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828 [TBL] [Abstract][Full Text] [Related]
39. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway. Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993 [TBL] [Abstract][Full Text] [Related]
40. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma. Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]